Pilot Study: A Dose-Response Finding Study of Ritodrine (Pre-Par) to Find the Highest Well Tolerated Dose in Young, Healthy, Female Volunteers. To Find the Size-Order of the Hemodynamical Effects of Ritodrine (PrePar) and Atosiban (Tractocile) to Determine the Relevance of a PK[pharmacokinetic]/PD [pharmacodynamic]-Modelling in the Final Study. Final Study: Investigating the Influence of Tocolytical Medications: Ritodrine (PrePar) Atosiban (Tractocile) at the Clinical Dose on the Hemodynamics and Arterial Function in Healthy Female Volunteers, Compared to Placebo During Continuous Intravenous Infusion

Trial Profile

Pilot Study: A Dose-Response Finding Study of Ritodrine (Pre-Par) to Find the Highest Well Tolerated Dose in Young, Healthy, Female Volunteers. To Find the Size-Order of the Hemodynamical Effects of Ritodrine (PrePar) and Atosiban (Tractocile) to Determine the Relevance of a PK[pharmacokinetic]/PD [pharmacodynamic]-Modelling in the Final Study. Final Study: Investigating the Influence of Tocolytical Medications: Ritodrine (PrePar) Atosiban (Tractocile) at the Clinical Dose on the Hemodynamics and Arterial Function in Healthy Female Volunteers, Compared to Placebo During Continuous Intravenous Infusion

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Apr 2011

At a glance

  • Drugs Atosiban (Primary) ; Ritodrine
  • Indications Preterm labour
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Apr 2011 Cardiovascular results published in the European Journal of Clinical Pharmacology.
    • 01 May 2009 Planned end date (1 Nov 2008) added as reported by ClinicalTrials.gov.
    • 01 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top